Kombinationstherapie mit einem Mitosehemmer

European patent · EP2786754 · In force

Register entry

Publication number
EP2786754
Application number
EP14175268
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 11, 2011
Published
Oct 8, 2014
Granted
Jan 9, 2019
Protection ends at the latest
Nov 10, 2031
Next annual fee due
Nov 30, 2026
IPC classes
A61K 31/4995 (2006.01)
A61K 31/513 (2006.01)
A61K 31/519 (2006.01)
A61K 31/69 (2006.01)
A61K 31/7068 (2006.01)
A61K 38/15 (2006.01)
A61K 45/06 (2006.01)
A61P 35/00 (2006.01)
A61K 31/337 (2006.01)
A61K 31/475 (2006.01)
Priority
EP 10382300 12.11.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 6, 2022

    Change

    Published in Swissreg on 06.12.2022

  5. Jan 9, 2019

    Granted

    Published in Swissreg on 09.01.2019

Parties

Holder

PHARMA MAR, S.A.

Pharma Mar S.A.

Avda. de los Reyes, 1 Polígono Industrial La Mina-Norte, 28770 Colmenar Viejo Madrid, ES

Inventor

GARCÍA FERNÁNDEZ, Luis Francisco

28770 Colmenar Viejo- Madrid, ES

GALMARINI, Carlos María

28770 Colmenar Viejo- Madrid, ES

MONEO OCAÑA, Victoria

28770 Colmenar Viejo- Madrid, ES

SANTAMARÍA NÚÑEZ, Gema

28770 Colmenar Viejo- Madrid, ES

AVILÉS MARÍN, Pablo Manuel

28770 Colmenar Viejo- Madrid, ES

GUILLÉN NAVARRO, María José

28770 Colmenar Viejo- Madrid, ES

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.